157 filings
Page 5 of 8
8-K
85mtwlcagvff
10 Jul 18
Entry into a Material Definitive Agreement
5:18pm
8-K
f2ksvv ny
3 Jul 18
Unregistered Sales of Equity Securities
4:05pm
8-K
cnc6dpve6a5nc4cd7qp
7 Jun 18
Departure of Directors or Certain Officers
4:30pm
8-K
mqdvyy10iu784ckak
31 May 18
Biostage Closes $3.6 Million Private Placement at a price of $3.60 per share
5:10pm
8-K
cmvz1w4
25 May 18
Submission of Matters to a Vote of Security Holders
4:11pm
8-K
jtil8rz zd0s1s1
10 May 18
Biostage Reports 2018 First Quarter Financial Results
8:05am
8-K
7s2h hm9z6
3 May 18
Entry into a Material Definitive Agreement
5:14pm
8-K
0bks0 ejxr
6 Apr 18
Changes in Registrant's Certifying Accountant
12:00am
8-K
bx0rb8c6h
2 Apr 18
Biostage Reports 2017 Financial Results
12:00am
8-K
tom9 rbbx01
30 Mar 18
Biostage Names Distinguished Children’s Hospital Executive James Shmerling to its Board of Directors
12:00am
8-K
yg0ixkbdv6vdzjm5volr
22 Feb 18
Unregistered Sales of Equity Securities
12:00am
8-K
xa1h y8xwfollj5
14 Feb 18
Regulation FD Disclosure
12:00am
8-K
euop72o7l8xmuj
13 Feb 18
Regulation FD Disclosure
12:00am
8-K
qly9gvh
8 Feb 18
Entry into a Material Definitive Agreement
12:00am
8-K
nzdq0fq
7 Feb 18
Biostage, Inc. Names Jason Chen Chairman of its Board of Directors
12:00am
8-K
rhg2cjrs4ta3u
3 Jan 18
Biostage Closes $4.2 Million Private Placement
12:00am
8-K
1rj7 3g980plk37k3v8t
22 Dec 17
Material Modifications to Rights of Security Holders
12:00am
8-K
rxmje
14 Dec 17
Biostage Announces Binding Agreement For $4.0 Million Private Placement
12:00am
8-K
akcnfmzcdxk
7 Dec 17
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
12:00am
8-K
rbhsiw9zps0qs2
12 Oct 17
Biostage Conducts Reduction In Force, Evaluating Strategic Alternatives
12:00am